A collection of stories about our people, our capabilities, our insights and the ever-changing face of our firm.
Public intent to receive a COVID-19 vaccine is more nuanced than most polling captures and more optimistic for public health than is being widely reported.
Purple partner Chris Durlak is a featured expert in the latest issue of The CEO Forum magazine, sharing insights for CEOs from Purple Futurecasting.
As the COVID crisis has worsened across the U.S. since summer, partisan attitudes have shifted on whether it's more of a health or economic crisis.
Political alliances are shifting, and headwinds and tailwinds are becoming harder to read. What we see, what it means, and what you should do about it.
Where a person gets their news and their political party identification drive unique factors of COVID-19 vaccine hesitancy.
What challenges and opportunities lie ahead for corporate reputation? Get in-depth perspectives from leaders who are building and protecting their company’s reputation, every day.
Right now the pharmaceutical industry enjoys both public optimism about its work and public demand to hear more about it. Companies need to capitalize.
Moving any audience requires understanding the lens shaping their perspective. Today's political lens on COVID-19 has Americans seeing two distinct crises, and leaders must bridge the divide to get through.
Purple's Jordan Davis and Lauren Hickey offer three actions corporate leaders can take on the heels of the first presidential debate.
Data visualization of the structure and theme of the candidates’ convention speeches serves as one guide for what to watch and listen for in the debates.